Year: 2026

LAS VEGAS and WILMINGTON, Del., June 09, 2026 (GLOBE NEWSWIRE) — Acorn Energy, Inc. (Nasdaq: ACFN), a provider of remote monitoring and control solutions for generators, gas pipelines, cell tower campuses and other critical infrastructure, will webcast from Planet MicroCap Las Vegas 2026 Powered by MicroCapClub on Wednesday, June 17th at 12:30 am PT. Acorn’s CEO Jan Loeb and CFO Tracy Clifford will be available for in-person investor meetings on June 17th and 18th at booth #211. The event will be held at the Bellagio Hotel. Acorn continues to grow its annually recurring revenue from an expanding base of monitored endpoints––the core value driver of its business. Monitoring revenue grew 11.7% in Q1’26 to $5.7M on a latest-twelve-month (LTM) basis, driving a blended LTM gross margin of 78%. Acorn is also expanding the breadth and...

DALLAS, June 09, 2026 (GLOBE NEWSWIRE) — Applied Digital Corporation (NASDAQ: APLD) (“Applied Digital” or the “Company”), a leading designer, builder and operator of high-performance, sustainably engineered data centers and colocation services for Artificial Intelligence (“AI”), networking, and blockchain workloads, today announced that its subsidiary, APLD ComputeCo 3 LLC (“APLD ComputeCo 3”), intends to offer, subject to market conditions and other factors, $1.59 billion aggregate principal amount of senior secured notes due 2031 (the “Notes”), in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act. APLD...

Dubai and New York, June 9, 2026 — VEON Ltd. (NASDAQ: VEON), a global digital operator (the “Company” or “VEON”), today announces the appointment of Serkan Ozturk as Chief of Staff & Strategy Officer, effective June 9, 2026. Serkan will join the VEON Leadership Team and report directly to the Group Chief Executive Officer. In this role, he will support the Group in translating VEON’s strategic ambitions into disciplined execution, ensuring alignment across functions, and driving coordination and delivery of priority Group initiatives. Serkan joined VEON in November 2025 as Group Director, Mergers & Acquisitions, where he has supported the Group’s strategic and investment agenda. Prior to joining VEON, Serkan most recently served as Group CIO at Dias Teknoloji. Before this, he spent 24 years at Turkcell, including 8 years as Group...

VenHub enters the Florida market through a new operator-led deployment model, marking a key step in its U.S. commercial rollout LAS VEGAS, June 09, 2026 (GLOBE NEWSWIRE) — VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced its expansion into the Florida market through a new commercial deployment with a local operator. The initial rollout will target the Tampa Bay region, representing VenHub’s first “Powered by VenHub” presence in the state. The expansion reflects VenHub’s broader commercial strategy of enabling local operators to deploy and brand autonomous retail locations using its fully integrated infrastructure platform, bringing enterprise-grade retail technology to high-traffic environments without the labor overhead, shrinkage exposure, or...

– BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham  – Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma – Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers – Elraglusib has received FDA Rare Pediatric Disease designation for neuroblastoma CHICAGO and FORT WORTH, Texas, June 09, 2026 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU), a clinical-stage biopharmaceutical company focused on developing novel therapies for difficult-to-treat cancers, today announced that elraglusib will be evaluated in the BEACON2 clinical...

VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces the company been added as a member of the broad-market Russell 3000® Index effective at market open on June 29, 2026, as part of the first 2026 Russell indexes reconstitution. The inclusion reflects ZenaTech’s continued growth and market capitalization and is expected to broaden the Company’s credibility and exposure to investors, including institutional investors, ETFs, and index funds that track Russell small-cap companies. “Being added to the Russell 3000® Index is a significant achievement for ZenaTech and...

SINGAPORE, June 09, 2026 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for May 2026. “In May, BitFuFu delivered strong operational results with total Bitcoin production rising 22.1% month-over-month to 177 BTC. The more significant story, however, was the strategic shift in our production mix: self-mining output nearly tripled to 90 BTC in May from 32 BTC in April and accounted for more than half of total production. This reflects a deliberate capital allocation decision. We view the current Bitcoin price environment as an attractive long-term accumulation opportunity, and we have proactively shifted resources toward self-mining to build our Bitcoin holdings. We remain...

Milestone Demonstrates Viability of PureCycle’s Recycled Resin in High-Performance Flexible Packaging for Snack, Confectionery and Roll-Fed Label Applications ORLANDO, Fla., June 09, 2026 (GLOBE NEWSWIRE) — PureCycle Technologies, Inc. (Nasdaq: PCT), today announced the successful production and trial evaluation of white, cavitated biaxially oriented polypropylene (BOPP) film in collaboration with Innovia Films, a leading material science pioneer and global manufacturer of packaging, graphics and label films. The film was produced using PureCycle’s PureFive Choice™ resin, and the film contains more than 40% post-consumer recycled (PCR) content. This film will be marketed to brand owners interested in introducing recycled content to their own white, cavitated BOPP applications.  White, cavitated BOPP film is a critical...

To Nasdaq Copenhagen A/S                                                                              June 9, 2026                                         Announcement No. 48/2026 Notice of Extraordinary General Meeting of Jyske Realkredit A/S on Thursday, June 25, 2026, at 7:30 a.m. at the company’s address: Kalvebod Brygge 3, 1560 Copenhagen V. Agenda for consideration and final adoption It is proposed that annual reports may be prepared in English, and accordingly, an amendment to the Articles of Association must be adopted pursuant to Art.100a of the Danish Companies Act if the general meeting approves the proposal.Proposed amendment to the Articles of Association: Art. 12, new (2): “Annual reports shall be prepared and presented in English. The Supervisory Board may determine that annual reports shall also be prepared in Danish.” Motion...

Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatment, with Decline in Severe Functional Impairment from 85% to 0% BURLINGTON, Mass. and JERUSALEM, June 09, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the presentation of new prospective 12-month durability data demonstrating sustained clinical benefits following accelerated Deep Transcranial Magnetic Stimulation (Deep TMS™) for Major Depressive Disorder (MDD). The findings were recently presented in a poster by Colleen Hanlon, PhD, Vice President of Medical Affairs for BrainsWay, at the 14th Annual Clinical TMS Society (CTMSS) Meeting which was held on June 4-6, 2026. The data represented outcomes from the first multisite,...